Dan The Bio Man retweeted
We want to welcome @Geovax_News to the @ROTHCapital Partners 3rd Annual Healthcare Opportunities Conference October 9th. See their profile on @B2iDigital at b2idigital.com/3rd-annual-ro…
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers using novel proprietary platforms. GeoVax’s product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and therapy for advanced head and neck cancer. Additional development programs include preventive vaccines against Mpox and smallpox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, and Marburg), malaria and Zika virus, as well as therapies for various solid tumors. (Source: Company Website 08.06.24)
We look forward to seeing the continued results from David A. Dodd, Arban Domi, Mary Hauser, Susan Hensley, MS, RAC, Kelly McKee, Mark Newman, John Niles, Tom O'Brien, Sreenivasa Rao Oruganti, J. Marc Pipas, MD, Erica Raiden, Mark Reynolds, John W. Sharkey, Jeff Welch, Ashley Zuniga, PhD PMP and the entire GeoVax Labs, Inc. team!
Thanks to the stellar team at ROTH for organizing this conference: Sagar Sheth, Byron Roth, Isabel Mattson-Pain, Amanda McAdams, Otilia "Charo" Montano, Benjamin Bowen, James Antonopoulos, Jason Wittes, Jonathan Aschoff, Ph.D., Boobalan Pachaiyappan, Ph.D. and many others
ROTH is a relationship-driven investment bank headquartered in Newport Beach, CA. For more information on ROTH, please visit roth.com.
We hope you’ll be able to attend this pivotal event shaping the future of healthcare innovation.
Dan The Bio Man retweeted
Raising awareness for rare diseases is critical in order to support companies committed to finding treatments for these patients and their families.
#RareDiseases #RareDiseaseDay #Awareness #Treatments @BioUtah @BioHiveUtah @RecursionPharma $RXRX
Today is #RareDiseaseDay We are marking this occasion with a Utah Rare Disease Day event this evening at @RecursionPharma With nearly 350k Utahns with a rare disease, we continue to work together to promote medical innovation and advance care and cures.
Dan The Bio Man retweeted
Developing the first ever single-use, disposable, hand-held test to aid in the detection of kennel cough. buff.ly/2HTba69 #Biofuture2022 #Medtech #kennelcough #veterinaryclinics #clinics @demycolton
Dan The Bio Man retweeted
10 Reasons to Keep an Eye on Chicago Biotech in 2023 buff.ly/3D7LHDb
Dan The Bio Man retweeted
The #BioHiveSummit agenda is live! We will be announcing our featured speakers in the coming weeks.
We are excited for @GovCox to join us for opening remarks to kick-off our day at the Salt Palace.
Register now: https://xitter.cf/t.co/qsPkCpPD2T
Dan The Bio Man retweeted
Alphabet's AI predicted the structure of 200 million proteins. Can it really speed up drug discovery? buff.ly/3sacDMq
Dan The Bio Man retweeted
The annual BioHive Summit presented by Mayer Brown is live and in-person this year. The event is scheduled for November 10, 2022 at the Salt Palace.
Early bird registration is now open and goes through midnight October 23.
Register here: biohivesummit.com/
Dan The Bio Man retweeted
Using proprietary bilayer tablet technology to treat constipation, metabolic disorder, and hepatic encephalopathy. buff.ly/2HTba69 #Biofuture2022 #pharmaceutical #colondisease #metabolicdisorder #drug @demycolton
Dan The Bio Man retweeted
As government funding dries up, Pfizer expects to charge private payers $110+ for Covid-19 vaccine buff.ly/3zhyWnw
Dan The Bio Man retweeted
Automatically building large databases of images and data on live cells and tissues for data mining, machine learning and breakthrough insights. buff.ly/2HTba69 #Biofuture2022 #biotechnology #data #cells #cellimaging #breakthrough #machinelearning @demycolton
Dan The Bio Man retweeted
GEO-CM04S1 targets both the spike and nucleocapsid proteins, in contrast to the current FDA-approved COVID-19 vaccines, which only target the spike protein.
thelancet.com/journals/lanmi…
#COVID-19 #vaccine #FDA #immunereponse #TCells #immunocompromised @LancetMicrobe $GOVX































